Yulei Wang

12PUBLICATIONS
81CO-AUTHORS
Molecular targetsPredictive and prognostic markersTumour immunologyHaematological tumoursChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 25, 2026
VSIG4 Restricts Hepatocellular Carcinoma Control by Suppressing Tumor-Specific CD8+ T-cell Immunity in the Tumor Microenvironment.

Jinglong Guo, Siddheshvar Bhela, Monica Sharma

|Dec 03, 2025
Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations.

Tianshi Lu, Habib Hamidi, Mark A Socinski

|Nov 17, 2025
Targeting tumor-intrinsic BCL9 reverses immunotherapy resistance by eliciting macrophage-mediated phagocytosis and antigen presentation.

Sui-Yi Wu, Yuan-Yuan Zhu, Jia-Lei Sun

|Dec 23, 2024
Precision targeting of β-catenin induces tumor reprogramming and immunity in hepatocellular cancers.

Brandon M Lehrich, Evan R Delgado, Tyler M Yasaka

|Nov 19, 2024
NOTCH1 Drives Sexually Dimorphic Immune Responses in Hepatocellular Carcinoma.

Katherine E Lindblad, Romain Donne, Ian Liebling

|Oct 18, 2024
Atezolizumab Plus Chemotherapy With or Without Bevacizumab in Advanced Biliary Tract Cancer: Clinical and Biomarker Data From the Randomized Phase II IMbrave151 Trial.

Teresa Macarulla, Zhenggang Ren, Hong Jae Chon

Pageof 2

Frequent Collaborators

3 joint publications

Sören Müller

3 joint publications

Shannon Turley

3 joint publications

Amaia Lujambio

2 joint publications

Mélanie Desbois